Get started
Author

Gabriele Magliano

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021 · Livio Pagano, Jon Salmanton-García, et al. · Journal of Hematology & Oncology · 316
PDF
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
2022 · Francesco Marchesi, Jon Salmanton-García, et al. · Haematologica · 50
PDF
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
2023 · Alessandro Busca, Jon Salmanton-García, et al. · Frontiers in Immunology · 38
PDF
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 35
PDF
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
2023 · Giuseppe Rossi, Jon Salmanton-García, et al. · International Journal of Infectious Diseases · 19
PDF
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
2022 · Maria Stefania Infante, Jon Salmanton-García, et al. · Frontiers in Oncology · 19
PDF
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report
2024 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 17
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
2023 · Pellegrino Musto, Jon Salmanton‐García, et al. · Hematological Oncology · 16
PDF
Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia of the Elderly: Review of the Literature and Perspectives.
2020 · Gabriele Magliano, Andrea Bacigalupo · Mediterranean Journal of Hematology and Infectious Diseases · 15
PDF
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
2024 · Tobias Lahmer, Jon Salmanton-García, et al. · Infection · 10
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
2023 · Monia Marchetti, Jon Salmanton-García, et al. · Therapeutic Advances in Hematology · 9
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
2022 · Chiara Cattaneo, Jon Salmanton-García, et al. · Cancers · 9
PDF
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent
2025 · Alessia Cavalleri, Besjana Xhahysa, et al. · Cell Biology International · 7
Nutritional Strategies To Improve VRE Control
2024 · Enrico Morello, Sara Roversi, et al. · Transplantation and Cellular Therapy · 6
Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient
2021 · Gabriele Magliano, Annarosa Cuccaro, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 4
PDF
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry
2025 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 2
PDF
Implementation of Routine Endoscopy with Narrow Band Imaging in the Evaluation of Oral and Upper Airways Lesions in Oral Chronic Graft-Versus-Host Disease: A Preliminary Study
2022 · Letizia Nitro, Carlotta Pipolo, et al. · Journal of Personalized Medicine · 2
PDF
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
2026 · Jon Salmanton-García, Francesco Marchesi, et al. · Open Forum Infectious Diseases · 1
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study
2025 · Mirko Farina, Filippo Bergamelli, et al. · Blood · 1
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50
2025 · Eugenia Accorsi Buttini, Alberto Zucchelli, et al. · Cancers · 1
PDF
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis
2024 · Mirko Farina, Marco Chiarini, et al. · Blood · 1
Potential selection of unrelated donor based on HLA-DPB1 T-cell epitope matching using data from a single-center analysis
2022 · Roberto Crocchiolo, Debora Girgenti, et al. · Bone Marrow Transplantation · 1
Successful treatment with gilteritinib for popliteal extramedullary relapse of FLT-3-ITD acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation : a case report and literature review
2026 · Gabriele Magliano, Mirko Farina, et al. · Research Square
PDF
Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo)
2026 · Daniele Avenoso, Mirko Farina, et al. · Open Forum Infectious Diseases
Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality
2026 · Daniele Avenoso, Natalia Difrancesco, et al. · Mediterranean Journal of Hematology and Infectious Diseases
PDF
Works count: 47
Citation count: 579
H-index: 10
I10-index: 10
Year
Topic
Type